Vylor (NYSE:VYLR – Get Free Report) had its price objective lowered by analysts at UBS Group from $89.00 to $87.00 in a report released on Friday, Benzinga reports. The firm presently has a “buy” rating on the stock. UBS Group‘s price objective would suggest a potential upside of 20.11% from the stock’s current price.
A number of other equities analysts have also recently commented on VYLR. KeyCorp initiated coverage on shares of Vylor in a research report on Wednesday, October 7th. They set a “sector weight” rating and a $78.00 price objective for the company. The Goldman Sachs Group began coverage on shares of Vylor in a research report on Thursday, October 8th. They issued a “buy” rating and a $87.00 price objective on the stock. Royal Bank Of Canada started coverage on shares of Vylor in a research note on Friday, October 2nd. They set an “outperform” rating and a $85.00 target price for the company. Mizuho began coverage on shares of Vylor in a research note on Monday, October 5th. They set an “outperform” rating and a $84.00 target price for the company. Finally, Weiss Ratings raised shares of Vylor from a “sell (d+)” rating to a “hold (c+)” rating in a report on Friday, October 16th. Two equities research analysts have rated the stock with a Strong Buy rating, eight have given a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat.com, Vylor has an average rating of “Moderate Buy” and a consensus price target of $82.50.
Read Our Latest Stock Report on Vylor
Vylor Trading Up 0.5%
Shares of NYSE VYLR traded up $0.38 during midday trading on Friday, hitting $72.44. 949,693 shares of the company’s stock were exchanged, compared to its average volume of 4,727,629. Vylor has a 12 month low of $65.00 and a 12 month high of $77.39.
Vylor (NYSE:VYLR – Get Free Report) last posted its earnings results on Thursday, November 12th. The company reported ($0.42) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.52) by $0.10. The business had revenue of $938.00 million for the quarter, compared to analyst estimates of $846.03 million. Vylor’s revenue was down .6% on a year-over-year basis. On average, equities analysts anticipate that Vylor will post 2.33 earnings per share for the current year.
Vylor declared that its Board of Directors has approved a share repurchase plan on Thursday, October 22nd that permits the company to buy back $3 billion in shares. This repurchase authorization permits the company to buy up to 6.3% of its stock through open market purchases. Share repurchase plans are usually an indication that the company’s management believes its shares are undervalued.
About Vylor
Vylor Inc. is a seed and genetics company. It develops and supplies germplasm for farmers to improve crop health and produce higher yields. Vylor Inc. is based in JOHNSTON, Iowa.
See Also
- Five stocks we like better than Vylor
- Firefly Aerospace Lights Up a High-Risk Space Opportunity
- Is Buying the NVIDIA Dip a Mistake? 3 Value Stocks Offer a Different Path Forward
- Costco’s Record $30 Dividend Shows Just How Strong Its Cash Machine Is
- Heavy Lifting: Can USA Rare Earth Turn Its First Sales Into Big Profits?
Receive News & Ratings for Vylor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vylor and related companies with MarketBeat.com's FREE daily email newsletter.
